WHO ICTRP trial
Quantifying disease progression in LBSL
NL-OMON54947 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON54947 |
|---|---|
| Public title | Quantifying disease progression in LBSL |
| Scientific title | Quantifying disease progression in LBSL - Disease progression in LBSL |
| Primary sponsor | Academisch Medisch Centrum |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Observational invasive |
| Countries | The Netherlands |
| Conditions | Leucoencephalopathy with brainstem and spinal cord involvement and lactate elevation; DARS2;10029299;10041543;Leucoencephalopathy with brainstem and spinal cord involvement and lactate elevation; DARS2 |
| Interventions | ;LBSL;Leukodystrophy;myelopathy |
| Registration date | May 3, 2021 |
| Target size | 90 |
| Secondary IDs | NL74024.018.21 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: